GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain

The oncologist

article

Miguel Martin¹  José Ignacio Chacón³  Josefina Cruz⁴  Julia Gimenez⁵  Luis Cruz-Merino⁶  Manel Algara⁷  Marta Santisteban⁸  Sara López Tarruella¹  Angel Guerrero-Zotano⁵  Ángel Montero⁹  Carlos Jara^1,10  Elena Filipovich^1,11  Federico Rojo²  Fernando Moreno^1,13  Jose Ángel García-Sáenz²  Jose Enrique Alés^1,11 

[1] Instituto de Investigación Sanitaria Gregorio Marañón, Departamento de Medicina, Universidad Complutense;Centro de Investigación Biomedica en Red de Oncologia, CIBERONC-ISCIII;Hospital Virgen de la Salud de Toledo;Hospital Universitario de Canarias;Instituto Valenciano de Oncología;Hospital Virgen de Macarena de Sevilla;Hospital del Mar de Barcelona;Clínica Universidad de Navarra;Hospital HM Sanchinarro;Universidad Rey Juan Carlos, Hospital Fundación Alcorcón;Medical Oncology, Complejo Asistencial de Ávil;Hospital Fundación Jimenez Díaz de Madrid;Hospital Universitario Clínico San Carlos de Madrid

关键词: Breast cancer;    Pandemic;    COVID-19;    SARS-CoV-2;    Expert recommendations;   

DOI  :  10.1634/theoncologist.2020-0363

学科分类：地质学

来源: AlphaMed Press Incorporated

【 摘 要 】

Breast cancer (BC) is the most common cancer in women in Spain. During the COVID-19 pandemic caused by the SARS-CoV-2 virus, patients with BC still require timely treatment and follow-up; however, hospitals are overwhelmed with infected patients and, if exposed, patients with BC are at higher risk for infection and serious complications if infected. Thus, health care providers need to evaluate each BC treatment and in-hospital visit to minimize pandemic-associated risks while maintaining adequate treatment efficacy. Here we present a set of guidelines regarding available options for BC patient management and treatment by BC subtype in the context of the COVID-19 pandemic. Owing to the lack of evidence about COVID-19 infection, these recommendations are mainly based on expert opinion, medical organizations' and societies' recommendations, and some published evidence. We consider this a useful tool to facilitate medical decision making in this health crisis situation we are facing. Implications for Practice This work presents a set of guidelines regarding available options for breast cancer (BC) patient management and treatment by BC subtype in the context of the COVID-19 pandemic. Owing to the suddenness of this health crisis, specialists have to make decisions with little evidence at hand. Thus, these expert guidelines may be a useful tool to facilitate medical decision making in the context of a worldwide pandemic with no resources to spare.

【 授权许可】

CC BY|CC BY-NC